A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury.
Memon AA, Ahmed H, Li Y, Wongboonsin J, Hundert J, Benoit S, Chaudhari A, Sher J, Ghimire P, Hopkins R, Patel J, Stegman M, Lim K, Azzi J, Siedlecki AM.
Memon AA, et al. Among authors: stegman m.
Kidney Int Rep. 2022 Dec;7(12):2714-2717. doi: 10.1016/j.ekir.2022.09.003. Epub 2022 Sep 12.
Kidney Int Rep. 2022.
PMID: 36120390
Free PMC article.
No abstract available.